PRiME Seminars in AI and Drug Discovery

The PRiME Seminars in AI and Drug Discovery series explores how artificial intelligence is transforming drug discovery, from molecular design to clinical prediction, by bringing leading researchers and industry experts together.

This session features Professor Teresa Head-Gordon, University Endowed Chair in Computational Science in the Departments of Chemistry, Bioengineering, and Chemical & Molecular Bioengineering at UC Berkeley, presenting "Machine Learning Foundations and Large Language Models are Here for In Silico Drug Discovery."

Professor Head-Gordon specializes in theoretical chemistry and biophysics, spanning quantum mechanics, AI/ML, water solvation, molecular interactions, and drug discovery. She directs CalSolv at UC Berkeley and co-directs the National Molecular Sciences Software Institute.

The seminar is open to all, with hybrid attendance available on request. Graduate students may register for PHM3100 (0.13 FCE, CR/NCR) to have attendance transcripted.